Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$217.9K
TTM
Current Assets
$102.5K
Q4 2022
Current Liabilities
$442.9K
Q4 2022
Current Ratio
23.14%
Q4 2022
Total Assets
Q4 2022
Total Liabilities
Q4 2022
Book Value
-$603.4K
Q4 2022
Cash
P/E
-0.8993
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $0.00
Gross Profit $0.00
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Selling, General & Admin $163.3K $68.72K $5.540K $5.680K $27.82K $44.99K -$1.107M $2.327M $2.462M $12.34K $20.22K $20.00K $20.00K $20.00K $10.00K
YoY Change 137.63% 1140.43% -2.46% -79.58% -38.16% -104.07% -147.55% -5.49% 19853.08% -38.97% 1.1% 0.0% 0.0% 100.0%
% of Gross Profit
Research & Development $30.00K
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $18.98K $12.74K $4.860K
YoY Change -100.0% 48.98% 162.14%
% of Gross Profit
Operating Expenses $163.3K $68.72K $5.535K $5.684K $27.82K $44.99K -$1.088M $2.339M $2.497M $12.34K $20.22K $20.00K $20.00K $20.00K $10.00K
YoY Change 137.63% 1141.57% -2.62% -79.57% -38.15% -104.14% -146.5% -6.34% 20135.66% -38.97% 1.1% 0.0% 0.0% 100.0%
Operating Profit -$163.3K -$68.72K -$5.535K -$5.684K -$27.82K -$44.99K $1.088M
YoY Change 137.63% 1141.57% -2.62% -79.57% -38.15% -104.14%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Interest Expense $32.08K $10.40K $9.476K $8.309K $5.584K $1.240K $0.00 -$2.200K -$696.6K
YoY Change 208.56% 9.72% 14.05% 48.8% 350.32% -100.0% -99.68%
% of Operating Profit 0.0%
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Pretax Income -$165.0K -$76.09K -$15.01K -$13.99K -$28.41K -$51.23K $1.088M -$2.341M -$3.759M -$12.34K -$20.22K -$20.00K -$20.00K -$20.00K -$10.00K
YoY Change 116.81% 406.93% 7.29% -50.76% -44.54% -104.71% -146.45% -37.72% 30360.45% -38.97% 1.1% 0.0% 0.0% 100.0%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$165.0K -$76.09K -$15.01K -$13.99K -$28.41K -$51.23K $1.162M -$2.308M -$3.759M -$12.34K -$20.22K -$20.00K -$20.00K -$20.00K -$10.00K
YoY Change 116.81% 406.89% 7.28% -50.74% -44.55% -104.41% -150.36% -38.6% 30360.45% -38.97% 1.1% 0.0% 0.0% 100.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.105K -$971.00 -$191.50 -$178.50 -$362.50 -$653.70 $14.36K -$29.47K -$49.96K -$37.31 -$61.13 -$60.47 -$60.95 -$66.67 -$33.33

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Cash & Short-Term Investments $127.6K $261.2K $410.00 $530.00 $2.270K $2.990K $1.300K $201.7K $451.4K $4.910K $4.960K $0.00 $20.00K $10.00K $20.00K
YoY Change -51.14% 63595.12% -22.64% -76.65% -24.08% 130.0% -99.36% -55.33% 9094.09% -1.01% -100.0% 100.0% -50.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $2.750K $0.00 $57.63K $6.840K $0.00 $3.270K $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 742.54% -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $130.4K $261.2K $410.00 $530.00 $2.270K $2.990K $1.300K $259.3K $458.3K $4.910K $8.230K $10.00K $20.00K $10.00K $20.00K
YoY Change -50.09% 63595.12% -22.64% -76.65% -24.08% 130.0% -99.5% -43.42% 9233.4% -40.34% -17.7% -50.0% 100.0% -50.0%
Property, Plant & Equipment $0.00 $1.340K
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $2.500K $2.500K $0.00
YoY Change -100.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $22.08K $32.64K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -32.35%
Total Assets $130.4K $261.2K $410.00 $530.00 $2.270K $2.990K $1.300K $281.4K $490.9K $4.910K $8.230K $10.00K $20.00K $10.00K $20.00K
YoY Change
Accounts Payable $224.6K $214.1K $162.5K $157.1K $153.2K $163.1K $130.4K $70.24K $54.43K $9.640K $16.13K $10.00K $10.00K $0.00 $0.00
YoY Change 4.86% 31.75% 3.44% 2.57% -6.07% 25.06% 85.65% 29.05% 464.63% -40.24% 61.3% 0.0%
Accrued Expenses $124.0K $35.20K $24.97K $15.50K $7.190K $7.600K $12.36K $39.15K
YoY Change 252.16% 40.97% 61.1% 115.58% -5.39% -38.51% -68.43%
Deferred Revenue
YoY Change
Short-Term Debt $10.00K $20.00K $20.00K $20.00K $20.00K $25.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -50.0% 0.0% 0.0% 0.0% -20.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $358.5K $269.3K $207.5K $192.6K $180.4K $195.7K $142.8K $288.6K $54.43K $44.15K $35.13K $10.00K $10.00K $0.00 $0.00
YoY Change 33.1% 29.8% 7.73% 6.79% -7.83% 37.07% -50.54% 430.28% 23.28% 25.68% 251.3% 0.0%
Long-Term Debt $263.0K $318.0K $43.00K $43.00K $43.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -17.3% 639.53% 0.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $263.0K $318.0K $43.00K $43.00K $43.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -17.3% 639.53% 0.0% 0.0%
Total Liabilities $621.5K $587.3K $250.5K $235.6K $223.4K $195.7K $142.8K $288.6K $54.43K $44.15K $35.13K $10.00K $10.00K $0.00 $0.00
YoY Change 5.82% 134.47% 6.32% 5.48% 14.15% 37.07% -50.54% 430.28% 23.28% 25.68% 251.3% 0.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $195.91 Thousand

About Retrieve Medical Holdings, Inc.

Retrieve Medical Holdings, Inc. engages in developing software for data mining, clinical decision support, natural language processing, and algorithmic testing to analyze a patient's accumulated medical records and lab results in real-time generating diagnostic support guidance. The company is headquartered in Bedminster, New Jersey. The company went IPO on 2010-05-17. Its natural language processor enhances physicians to understand the complex clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results, radiology reports and EKG interpretations. Once identified by its software and reviewed by the physician, the diagnoses are inserted into the medical record, along with supportive documentation and billing information. Its software increases the efficiency of physicians and improves patient outcomes. The Company’s software is integrated with the Epic and Cerner, two of the electronic medical record providers in the world. The target market for its software is medical center emergency departments.

Industry: Pharmaceutical Preparations Peers: International Stem Cell CORP Statera Biopharma, Inc. Dermata Therapeutics, Inc. Q BioMed Inc. PREMIER BIOMEDICAL INC Rubius Therapeutics, Inc. Scopus BioPharma Inc.